Characteristics of pathologic complete response for locally advanced rectal cancer

被引:5
|
作者
Cloos, Adam J. [1 ]
Schissel, Makayla [2 ]
Batra, Rishi [1 ]
Donahue, Steven R. [1 ]
Wenos, Chelsea D. [1 ]
Kumar, Terrence [1 ]
Leinicke, Jennifer A. [1 ]
Thompson, Jon S. [1 ]
Langenfeld, Sean J. [1 ]
机构
[1] Univ Nebraska Med Ctr, Dept Surg, 620 S 42nd St, Omaha, NE 68132 USA
[2] Univ Nebraska Med Ctr, Dept Biostat, Omaha, NE 68132 USA
来源
AMERICAN JOURNAL OF SURGERY | 2023年 / 226卷 / 06期
关键词
Rectal cancer; Pathologic complete response; Associative factors; NEOADJUVANT CHEMORADIOTHERAPY; THERAPY;
D O I
10.1016/j.amjsurg.2023.07.023
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Neoadjuvant chemoradiation (NACRT) is the standard of care for locally advanced rectal cancers. The purpose of this study was to determine patient and tumor factors associated with a pathologic complete response (pCR). Methods: The National Surgical Quality Improvement Program proctectomy-targeted database was utilized to identify all patients from 2016 to 2020 who underwent NACRT followed by proctectomy with curative intent for T3-4N0-2 rectal cancers. Results: A total of 1891 patients were included, of which 253 (13.4%) demonstrated a pCR. Pretreatment N0 staging was associated with a higher rate of pCR (18.9%) when compared to N1 (6.7%) and N2 (6.7%) (p < 0.0001). Patients clinically staged at T3N0 had the highest rate of pCR (19.5%). Gender, age, race, weight, smoking status, and tumor height were not associated with pCR. Conclusions: Patients with cN0 disease were more likely to experience a pCR compared to cN1-2 patients. Tumor height relative to anal verge or patient demographics were not associated with pCR. (c) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码:873 / 877
页数:5
相关论文
共 50 条
  • [41] Tumor size as a predictor of pathologic complete response (pCR) and survival in a prospective trial of chemoradiation for locally advanced rectal cancer.
    Kim, CS
    Anne, PR
    Mitchell, EP
    Palazzo, J
    Pequignot, E
    Fishel, R
    Goldstein, SD
    Isenberg, GA
    Curran, W
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 288S - 288S
  • [42] Total Neoadjuvant Therapy Treatment Sequence and its Impact on Pathologic Complete Response and Survival in Patients with Locally Advanced Rectal Cancer
    Petashnick, M.
    Mattessich, S. P.
    Schreiber, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E67 - E68
  • [43] Predictors of pathologic complete response in patients with residual flat mucosal lesions after neoadjuvant chemoradiotherapy for locally advanced rectal cancer
    Li, Changlong
    Guan, Zhen
    Zhao, Yi
    Sun, Tingting
    Li, Zhongwu
    Wang, Weihu
    Li, Zhexuan
    Wang, Lin
    Wu, Aiwen
    CHINESE JOURNAL OF CANCER RESEARCH, 2022, 34 (04) : 383 - 394
  • [44] Can we predict pathologic complete response before surgery for locally advanced rectal cancer treated with preoperative chemoradiation therapy?
    Kuo, Li-Jen
    Chiou, Jeng-Fong
    Tai, Cheng-Jeng
    Chang, Chun-Chao
    Kung, Ching-Huei
    Lin, Sey-En
    Hung, Chin-Sheng
    Wang, Weu
    Tam, Ka-Wai
    Lee, Hung-Chia
    Liang, Hung-Hua
    Chang, Yu-Jia
    Wei, Po-Li
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2012, 27 (05) : 613 - 621
  • [45] How to Achieve a Higher Pathologic Complete Response in Patients With Locally Advanced Rectal Cancer Who Receive Preoperative Chemoradiation Therapy
    Lee, Suk-Hwan
    ANNALS OF COLOPROCTOLOGY, 2019, 35 (01) : 3 - 8
  • [46] Changing trends of dowenstaging, sphincter preservation, and complete pathologic response over 8 years in locally advanced rectal cancer patients
    El Taani, H. A.
    Hashem, S. A.
    Al-Rashdan, A. F.
    Badheeb, A.
    Nour, A.
    Shelpai, W.
    Haddad, H.
    Morcos, B.
    Abbasi, S. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [47] The Impact of Pathologic Complete Response in Patients with Neoadjuvantly Treated Locally Advanced Rectal Cancer—a Large Single-Center Experience
    A.M. Dinaux
    R. Amri
    L.G. Bordeianou
    T.S. Hong
    J.Y. Wo
    L.S. Blaszkowsky
    J.N. Allen
    J.E. Murphy
    H. Kunitake
    D.L. Berger
    Journal of Gastrointestinal Surgery, 2017, 21 : 1153 - 1158
  • [48] Prevalence and Clinical Significance of Acellular Mucin in Locally Advanced Rectal Cancer Patients Showing Pathologic Complete Response to Preoperative Chemoradiotherapy
    Lim, Seok-Byung
    Hong, Seung-Mo
    Yu, Chang Sik
    Hong, Yong Sang
    Kim, Tae Won
    Park, Jin-hong
    Kim, Jong Hoon
    Kim, Jin Cheon
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2013, 37 (01) : 47 - 52
  • [49] KRAS Mutation in Locally Advanced Rectal Cancer is Independently Associated with a Lower Rate of Pathologic Complete Response Following Neoadjuvant Therapy
    Chow, O. S.
    Kuk, D.
    Keskin, M.
    Smith, J. J.
    Ordonez, N.
    Pelossof, R.
    Chen, C.
    Chen, Z.
    Avila, K.
    Nash, G.
    Temple, L. K.
    Weiser, M.
    Guillem, J. G.
    Paty, P. B.
    Berger, M.
    Patil, S.
    Garcia-Aguilar, J.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S18 - S18
  • [50] Aneuploidy of chromosome 8 and mutation of circulating tumor cells predict pathologic complete response in the treatment of locally advanced rectal cancer
    Wan, Jue-Feng
    Li, Xue-Qin
    Zhang, Jing
    Yang, Li-Feng
    Zhu, Ji
    Li, Gui-Chao
    Liang, Li-Ping
    Shen, Li-Jun
    Zhang, Hui
    Li, Jing
    Zhang, Yi-Tong
    Chen, Chang-Yue
    Zhang, Zhen
    ONCOLOGY LETTERS, 2018, 16 (02) : 1863 - 1868